Analysts expect revenue increase Vertex Pharma

Vertex Pharma will announce it's last quarter's results tomorrow. For this year the company, based in Boston revenue will be around 6.99 billion USD. This is according to the average of the analysts' estimates. This is rather significant more than 2021's revenue of 6.21 billion USD.

Historical revenues and results Vertex Pharma plus estimates 2021

The analysts expect for 2021 a net profit of 2.86 billion USD. The majority of the analysts expects for this year a profit per share of 11.21 USD. With this the price/earnings-ratio is 17.75.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a relatively high 2.28 percent.

Based on the current number of shares Vertex Pharma 's market capitalization equals 51.52 billion USD. -30

Historical stock prices Vertex Pharma from 2007 till 2021

On Monday the stock closed at 198.93 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.